首页> 外文期刊>Einstein (So Paulo) >Warfarin: pharmacological profile and drug interactions with antidepressants
【24h】

Warfarin: pharmacological profile and drug interactions with antidepressants

机译:华法林:抗抑郁药的药理作用和药物相互作用

获取原文
           

摘要

Oral anticoagulants are among the drugs with the greatest number of drug interactions. The concomitant use of several medications is a common practice in patients with cardiovascular problems, who often also present with depression; therefore, the probability of an interaction occurring between warfarin and the antidepressants is high, and may result in increased or decreased anticoagulant activity. Since the possible interactions between these two classes of drugs have been poorly explored in literature, with a risk to the patients who use them, we reviewed the pharmacology of warfarin and its possible interactions with antidepressants. Of the antidepressants analyzed, those that showed relevant effects on the interaction with warfarin were, in decreasing order: paroxetine, venlafaxine, fluoxetine, and duloxetine.
机译:口服抗凝剂是药物相互作用最大的药物之一。心血管疾病患者通常会伴有抑郁症,因此通常会同时使用几种药物。因此,华法林与抗抑郁药之间发生相互作用的可能性很高,并且可能导致抗凝活性增加或降低。由于在文献中很少探讨这两种药物之间的可能相互作用,从而给使用它们的患者带来风险,因此我们回顾了华法林的药理作用及其与抗抑郁药的可能相互作用。在所分析的抗抑郁药中,对与华法林相互作用产生相关影响的抗抑郁药的降序排列是:帕罗西汀,文拉法辛,氟西汀和度洛西汀。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号